Anna L. Moore, MPH

Original Contribution

Bivalirudin versus Heparin Plus Glycoprotein IIb/IIIa Inhibitors in Drug-Eluting Stent Implantations in the Absence of Acute Myo

08/01/2008

Gregory J. Mishkel , MD, FRCPC, FACC, FSCAI;

Anna L. Moore , MPH;

Stephen J. Markwell , MA, MS;

Robert W. Ligon , MS;

Bare-metal stents (BMS) lower the risk of restenosis and the need for repeat coronary revascularization compared to balloon angioplasty alone.1 The introduction of drug-eluting stents (DES) has further markedly decreased angiographic...

Bare-metal stents (BMS) lower...

08/01/2008

Journal of Invasive Cardiology

Original Contribution

Short- and Long-Term Clinical Outcomes of Coronary Drug-
Eluting Stent Recipients Presenting with Chronic Renal Disease

08/01/2008

Stephen J. Markwell , MA, MS;

Joji J. Varghese , MD, FACC, FSCAI;

Frank Aguirre , MD;

Marc Shelton , MD;

Gregory J. Mishkel , MD, FRCPC, FACC, FSCAI;

Anna L. Moore , MPH;

Chronic renal disease (CRD) is a common health concern in wealthy countries, with approximately 20 million American adults currently affected.1 While the association between renal insufficiency and increased risk of adverse non-fatal and...

Chronic renal disease (CRD) is a...

08/01/2008

Journal of Invasive Cardiology